Tanhaji, Hajina A.
HRN: 14-25-62 Sex: FemalePatient Encounter
Audit Details
Audit Date
Antimicrobial
Start Date
End Date
Route
Dose
Frequency
Indication Documented
03/28/2024
METRONIDAZOLE 5MG/ML, 100ML (VIAL)
03/28/2024
04/25/2024
TIV
500mg
Q8
AMOEBIASIS
Checking Final Appropriateness
Indication: Empiric Type of Infection: Intra-abdominal Compliance to guidelines: Compliant To Guidelines
Initial appropriateness: Yes